FRANKLIN RESOURCES INC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$78,785
-32.8%
24,853
+5.4%
0.00%
Q2 2023$117,173
-99.3%
23,576
-96.1%
0.00%
-100.0%
Q4 2019$15,866,000
-26.2%
610,697
-22.6%
0.01%
-33.3%
Q3 2019$21,498,000
+1.5%
788,7790.0%0.01%
+9.1%
Q2 2019$21,179,000
-6.4%
788,779
-0.0%
0.01%
-8.3%
Q1 2019$22,616,000
+68.2%
788,979
+58.1%
0.01%
+50.0%
Q4 2018$13,443,000499,1820.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders